Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (437) clinical trials

This study will be testing an investigational medication for COPD Eligibility Criteria: -Age 40 years or older -Diagnosis of COPD for at least 12 months -Current Smoker or Ex-Smoker -Other criteria may apply Other Details: Qualified volunteers will receive study medication, study supplies and any study required testing at no ...

Phase

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of 3-Month Subcutaneous REGN1033 Treatment in Patients with Sarcopenia

Phase

This is a placebo controlled trial to test the efficacy and safety of CHF 5259 (glycopyrronium bromide). This is an 8 week treatment trial.

Phase

A research study to evaluate the treatment in patients with Idiopathic Pulmonary Fibrosis (IPF)

Phase

Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging

In this study the efficacy of Roflumilast in addition to LAMA/LABA therapy will be assessed using Functional Respiratory Imaging. In total 40 Chronic obstructive pulmonary disease (COPD) patients, Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages C and D, who are stable on LABA/LAMA therapy and who are prone ...

Phase

A Double Blind Randomized Controlled Study to Compare CHF 5633 (Synthetic Surfactant) and Poractant Alfa in RDS

A multicenter, double blind, randomized, single dose, active-controlled study to investigate the efficacy and safety of synthetic surfactant (CHF 5633) in comparison to porcine surfactant (Poractant alfa, Curosurf ) in the treatment of preterm neonates with respiratory distress syndrome. Main objectives of this study are to investigate the short term ...

Phase

Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)

The objective of this study is to detect BOS in an early stage by using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive ...

Phase

RRx-001 in Small Non-small Cell Lung Cancer Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

This is an open label, four-arm, three stage, pilot study for co-administration of RRx-001 with autologous blood once weekly until progression followed by reintroduction of platinum-based doublet therapy. The study is designed to explore the potential of the epigenetic agent RRx-001 to sensitize patients who previously responded and now have ...

Phase

Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC

The investigators hypothesize that in a significant subset of patients with recurrent NSCLC immunotherapy after SBRT will be superior to treatment with immunotherapy alone and that SBRT, given to a single metastatic site of the tumor, will augment the immune response to the tumor. Objectives: Disease Control Rate (DCR), defined ...

Phase

Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis

The purpose of this study is to find out what effects, good and/or bad, the drug nintedanib in combination with steroids, has on the lungs. Furthermore, such treatments' side effects will be studied together with quality of life. In addition, the investigators would like to determine whether they can find ...

Phase